CLINICAL_TRIALS
trial_result
· 2024-06-24
Clinical Trial Update: Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus [Phase 2]
Summary
Sanofi's SAR443122 completed a Phase 2 proof-of-concept study in patients with cutaneous lupus erythematosus; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Cutaneous Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2024-06-24